{"id":"W1988988586","doi":"10.1001/archinternmed.2010.319","title":"Pregabalin for the Treatment of Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Randomized Controlled Trial","year":2010,"lang":"en","type":"article","venue":"Archives of Internal Medicine","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University","funders":"National Institute on Minority Health and Health Disparities; National Institute of Diabetes and Digestive and Kidney Diseases; Allergan; National Institutes of Health; Boston Scientific Corporation; Sanofi; GlaxoSmithKline; Pfizer","keywords":"Pregabalin; Medicine; Prostatitis; Placebo; Pelvic pain; Randomized controlled trial; Chronic prostatitis/chronic pelvic pain syndrome; Chronic pain; Internal medicine; Neuropathic pain; Physical therapy; Anesthesia; Surgery; Prostate","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001474846,0.0002493374,0.001838416,0.0002093531,0.00005842319,0.00000631225,0.0002129559,0.00004474029,0.0003463949],"category_scores_gemma":[0.0008786728,0.0001038937,0.0004251712,0.00009618668,0.001403609,0.00003394117,0.00002417119,0.0002503572,0.000001367558],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004605668,"about_ca_system_score_gemma":0.0005077201,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005470325,"about_ca_topic_score_gemma":0.0001944039,"domain_scores_codex":[0.9977413,0.0003696327,0.0008325046,0.0002589944,0.0004640552,0.0003335202],"domain_scores_gemma":[0.9899964,0.008954887,0.0003653232,0.0004117848,0.0001199906,0.0001516083],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9506785,0.000648595,0.0002554841,0.0004550738,0.002417852,0.00006528015,0.002403283,0.000004183435,0.01011129,0.000296364,0.0001962233,0.03246788],"study_design_scores_gemma":[0.909987,0.07477079,0.0003887656,0.001010114,0.000942887,0.000210735,0.0001959669,0.00759491,0.002855316,0.0004791447,0.00147396,0.00009042363],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9035755,0.01522424,0.01242792,0.009585989,0.0005904655,0.04459081,0.00007838015,0.00005272485,0.01387395],"genre_scores_gemma":[0.9889273,0.002186587,0.000573602,0.00003780889,0.0005447863,0.002255274,0.00003080879,0.0000326161,0.005411194],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08535181,"threshold_uncertainty_score":0.5171655,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01075333543073024,"score_gpt":0.3034345861069465,"score_spread":0.2926812506762163,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}